Effect of albumin administration on outcomes in hypoalbuminemic patients hospitalized with community-acquired pneumonia (ALBUCAP): a prospective, randomized, phase III clinical controlled trial—a trial protocol

BACKGROUND: Community-acquired pneumonia (CAP) remains a leading cause of death worldwide, and hypoalbuminemia is associated with worse outcomes. However, it remains uncertain whether albumin administration could have any beneficial effects. We aim to assess whether the administration of albumin in...

Descripción completa

Detalles Bibliográficos
Autores principales: Rombauts, Alexander, Abelenda-Alonso, Gabriela, Simonetti, Antonella Francesca, Verdejo, Guillermo, Meije, Yolanda, Ortega, Lucia, Clemente, Mercedes, Niubó, Jordi, Ruiz, Yolanda, Gudiol, Carlota, Tebé, Cristian, Videla, Sebastian, Carratalà, Jordi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7438978/
https://www.ncbi.nlm.nih.gov/pubmed/32819439
http://dx.doi.org/10.1186/s13063-020-04627-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7438978/
https://www.ncbi.nlm.nih.gov/pubmed/32819439
http://dx.doi.org/10.1186/s13063-020-04627-1

Ejemplares similares